Piedmont, CA, United States of America

Brian C Cunningham



Average Co-Inventor Count = 3.2

ph-index = 23

Forward Citations = 1,690(Granted Patents)


Location History:

  • San Bruno, CA (US) (1998 - 2000)
  • San Mateo, CA (US) (2000 - 2006)
  • Piedmont, CA (US) (1996 - 2014)

Company Filing History:


Years Active: 1996-2014

Loading Chart...
Loading Chart...
31 patents (USPTO):

Title: Innovations and Contributions of Brian C Cunningham in Biotechnology

Introduction

Brian C Cunningham, hailing from Piedmont, CA, is an accomplished inventor with a remarkable portfolio of 31 patents. His work primarily focuses on advancing biotechnological applications, particularly in the field of growth hormones and vascular endothelial growth factors (VEGF).

Latest Patents

Cunningham's latest patents reflect his innovative spirit and dedication to improving human health. One notable invention involves growth hormone variants, which introduces variants of human growth hormone with amino acid substitutions, specifically at residue R77. This advancement not only broadens the understanding of human growth hormone but also has potential therapeutic uses. Another significant patent is for VEGF variants that have one or more amino acid mutations in the KDR and/or FLT-1 receptor binding domains. This invention allows for selective binding affinity to either the KDR receptor or the FLT-1 receptor, offering new avenues for targeted therapies in treating various diseases.

Career Highlights

Throughout his career, Cunningham has contributed to significant advancements in biotechnology. He has held positions in renowned companies, including Genentech, Inc. and Genencor International, Inc. His work in these organizations has led to pioneering innovations that have impacted the healthcare industry profoundly.

Collaborations

Collaboration is key in the field of biotechnology, and Cunningham has had the pleasure of working alongside distinguished colleagues such as James A Wells and Richard Ray Bott. Their collective expertise and innovative approaches have enhanced the research and development processes in which they were involved.

Conclusion

Brian C Cunningham's contributions to biotechnology through his patents and collaborations underscore his role as a leading inventor in the field. His ongoing innovations in growth hormones and VEGF variants exemplify a commitment to advancing medical science and improving patient outcomes. The impact of his work will continue to resonate in the realms of health and medicine for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…